7,8-Dihydroxycoumarin exerts antitumor potential on DMBA-induced mammary carcinogenesis by inhibiting ERα, PR, EGFR, and IGF1R: involvement of MAPK1/2-JNK1/2-Akt pathway
暂无分享,去创建一个
[1] S. Jha,et al. Daphnetin ameliorates 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis through Nrf-2-Keap1 and NF-κB pathways. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[2] S. Jha,et al. EFFECT OF NARINGENIN ON LIPIDS, LIPOPROTEINS AND LIPID METABOLISING ENZYMES IN 7,12-DIMETHYL BENZ(A)ANTHRACENE-INDUCED MAMMARY CARCINOGENESIS IN SD RATS , 2016 .
[3] H. Piotrowska,et al. Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides , 2016, PloS one.
[4] S. Subramanian,et al. Tangeretin, a citrus flavonoid attenuates oxidative stress and protects hepatocellular architecture in rats with 7, 12 - dimethylbenz(a)anthracene induced experimental mammary carcinoma , 2015 .
[5] J. Morales-Montor,et al. The role of cytokines in breast cancer development and progression. , 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[6] Y. Shokoohinia,et al. Comparative Evaluation of Cytotoxic and Apoptogenic Effects of Several Coumarins on Human Cancer Cell Lines: Osthole Induces Apoptosis in p53-Deficient H1299 Cells , 2014, Advances in pharmacological sciences.
[7] Nahla S Hassan,et al. Umbelliferone and daphnetin ameliorate carbon tetrachloride-induced hepatotoxicity in rats via nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1 expression. , 2014, Environmental toxicology and pharmacology.
[8] P. Sunita,et al. Restorative effect of Dendrophthoe falcata (L.f.) Ettingsh on lipids, lipoproteins, and lipid-metabolizing enzymes in DMBA-induced mammary gland carcinogenesis in Wistar female rats , 2014, Comparative Clinical Pathology.
[9] J. Lee,et al. Positive Expression of Insulin-Like Growth Factor-1 Receptor Is Associated with a Positive Hormone Receptor Status and a Favorable Prognosis in Breast Cancer , 2014, Journal of breast cancer.
[10] S. Subramanian,et al. Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats. , 2014, Biochimie.
[11] J. Renoir,et al. Estrogen receptor signaling as a target for novel breast cancer therapeutics. , 2013, Biochemical pharmacology.
[12] S. Bulun,et al. Aromatase, breast cancer and obesity: a complex interaction , 2012, Trends in Endocrinology & Metabolism.
[13] Bart M. G. Smits,et al. Quantification of Epithelial Cell Differentiation in Mammary Glands and Carcinomas from DMBA- and MNU-Exposed Rats , 2011, PloS one.
[14] C. Lemini,et al. Differential effects of esculetin and daphnetin on in vitro cell proliferation and in vivo estrogenicity. , 2011, European journal of pharmacology.
[15] Gun-Hee Kim,et al. Anticancer mechanism of equol in 7,12-dimethylbenz(a)anthracene-treated animals. , 2011, International journal of oncology.
[16] M. Miyazaki,et al. Stromal MCP‐1 in mammary tumors induces tumor‐associated macrophage infiltration and contributes to tumor progression , 2009, International journal of cancer.
[17] M. Ellersieck,et al. Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study. , 2008, Endocrine-related cancer.
[18] E. Choi. Antioxidative effects of hesperetin against 7,12-dimethylbenz(a)anthracene-induced oxidative stress in mice. , 2008, Life sciences.
[19] Li Zhang,et al. Adipocytokines and breast cancer risk. , 2007, Chinese medical journal.
[20] M. Balasubramanian,et al. Protective effect of Operculina turpethum against 7,12-dimethyl benz(a)anthracene induced oxidative stress with reference to breast cancer in experimental rats. , 2007, Chemico-biological interactions.
[21] H. Zhang,et al. Expression of aromatase and 17β-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer An immunocytochemical study , 2006, The Journal of Steroid Biochemistry and Molecular Biology.
[22] W. Jiang,et al. The role of aromatase and 17-β-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer , 2006, Breast Cancer Research and Treatment.
[23] T. Hsieh,et al. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c. , 2004, International Journal of Oncology.
[24] J. Pasqualini. The selective estrogen enzyme modulators in breast cancer: a review. , 2004, Biochimica et biophysica acta.
[25] B. Creaven,et al. Daphnetin induced differentiation of human renal carcinoma cells and its mediation by p38 mitogen-activated protein kinase. , 2004, Biochemical pharmacology.
[26] F. Ye,et al. Anticancer activity of Scutellaria baicalensis and its potential mechanism. , 2002, Journal of alternative and complementary medicine.
[27] Shiuan Chen,et al. Prevention and Treatment of Breast Cancer by Suppressing Aromatase Activity and Expression , 2002, Annals of the New York Academy of Sciences.
[28] T. Kohama,et al. Effects of dehydroepiandrosterone and other sex steroid hormones on mammary carcinogenesis by direct injection of 7, 12-dimethylbenz(a) anthracene (DMBA) in hyperprolactinemic female rats , 1997, Breast Cancer Research and Treatment.
[29] R. Wood,et al. Which DNA polymerases are used for DNA-repair in eukaryotes? , 1997, Carcinogenesis.
[30] H Stein,et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.
[31] S. Mirkin,et al. Selective estrogen receptor modulators (SERMs): a review of clinical data. , 2015, Maturitas.
[32] J. Russo,et al. Role of Hormones in Mammary Cancer Initiation and Progression , 2004, Journal of Mammary Gland Biology and Neoplasia.